Holen Sie sich die Stockscreener-App
541.88
0.24%
-1.528
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$543.41
Offen:
$542.58
24-Stunden-Volumen:
96,439
Relative Volume:
0.05
Marktkapitalisierung:
$189.82B
Einnahmen:
$8.71B
Nettoeinkommen (Verlust:
$2.48B
KGV:
79.45
EPS:
6.82
Netto-Cashflow:
$1.75B
1W Leistung:
+3.63%
1M Leistung:
-1.86%
6M Leistung:
+3.85%
1J Leistung:
+24.26%
1-Tages-Spanne:
$540.00
$545.81
1-Wochen-Bereich:
$521.26
$545.81
52-Wochen-Spanne:
$413.82
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
542.16 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.95 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.10 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.37 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.68 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
ISRG vs BSX: Which Medical Device Stock Has More Room to Run? - The Globe and Mail
Virtual Incision Names Intuitive Veteran Jim Alecxih as CEO - Medical Product Outsourcing
Virtual Incision Appoints Jim Alecxih as Chief Executive Officer - Morningstar
Neurosurgery Surgical Robots Market Set to Witness Significant - openPR.com
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights - MSN
SS Innovations’ robot used in its first cardiac surgery in Americas - MedTech Dive
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision - The Globe and Mail
The Top 5 Analyst Questions From Intuitive Surgical’s Q1 Earnings Call - Yahoo Finance
Intuitive Surgical (ISRG): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
Unpleasant Surprises Could Be In Store For Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Shares - simplywall.st
Intuitive Surgical (ISRG) Earns 'Buy' Rating as Analyst Cites 'Ecosystem' Strength, Downplays Growth Threats - Daily Chhattisgarh News
William Blair Remains Bullish on Intuitive Surgical (ISRG) - MSN
Jim Cramer Notes “Intuitive Had Such a Great Quarter” - Insider Monkey
Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG) - Yahoo Finance
Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 20 Years - Benzinga
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst - Benzinga
Intuitive Surgical Ticks Higher, but Short-Term Downtrend Lingers Amid Strong Annual Gains - Daily Chhattisgarh News
BofA: Surgical robot remanufacturing not a major setback for Intuitive - MassDevice
Intuitive Surgical: The Market Might Exaggerate The Impact Of Remanufacturing (ISRG) - Seeking Alpha
AI-based Surgical Robots Market Generated Opportunities, - openPR.com
Intuitive Surgical Stock Is Falling. The MedTech Got Its First Sell Rating. - MSN
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com Nigeria
Virtua hospitals finalizing upgrade to latest robotic-assisted surgery technology - The Business Journals
Intuitive Surgical (ISRG) Share Price Continues Slide, Down Over 8% in a Month - Daily Chhattisgarh News
Micro Surgical Robot Market Set to Witness Significant Growth - openPR.com
Institutional investors in Intuitive Surgical, Inc. (NASDAQ:ISRG) lost 6.4% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Intuitive Surgical Stock Falls. The MedTech Company Gets Its First Sell Rating. - MSN
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - AllSides
Intuitive Surgical (ISRG) Stock Dips, Bucking Strong Long-Term Growth Trend - Daily Chhattisgarh News
Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead - Benzinga
ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong - Yahoo Finance
Intuitive Surgical analyst raises eyebrows with new stock price target - MSN
Intuitive Surgical Projects $165M Tariff Hit In 2025, Says Wait-And-See On Mitigation - insights.citeline.com
Capstan Medical's R&D head discusses the heart valve and robotics startup's tech, engineering challenges and solutions, advice for others in medtech and how to join his team - Medical Design & Outsourcing
Intuitive Surgical (ISRG) Ticks Up, But Faces Recent Headwinds Despite Strong Annual Gains - Daily Chhattisgarh News
Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views? - MSN
Tesla, Intuitive Surgical downgraded: Wall Street’s top analyst calls - Yahoo Finance
Deutsche Bank Sounds Alarm on Intuitive Surgical Stock (ISRG) with a Rare ‘Sell’ Rating - TipRanks
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now? - Yahoo Finance
Intuitive Surgical (ISRG) Faces Instrument Reprocessing Risks | ISRG Stock News - GuruFocus
AI-driven Surgical Planning Tools Market Is Booming Worldwide | Intuitive Surgical, Brainlab, Stryker, Zimmer Biomet - openPR.com
Intuitive Surgical (NASDAQ:ISRG) Lowered to Sell Rating by Deutsche Bank Aktiengesellschaft - Defense World
Intuitive Surgical Inc (ISRG) Stock Price Down 6.75% on Jun 9 - GuruFocus
Why Intuitive Surgical Stock Plunged Today - MSN
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Intuitive Surgical Inc-Aktie (ISRG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rosa David J. | President |
Jun 10 '25 |
Option Exercise |
0.00 |
1,358 |
0 |
232,430 |
| Brosius Mark | SVP & Chief Mfg and Supply Cha |
Jun 06 '25 |
Sale |
563.11 |
216 |
121,632 |
907 |
| Brosius Mark | SVP & Chief Mfg and Supply Cha |
Jun 05 '25 |
Sale |
560.70 |
215 |
120,551 |
1,123 |
0.66%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):